What is the appropriate dosing strategy for hydroxyzine to treat anxiety related to fear of flying in a woman who is in her second trimester of pregnancy?

Hydroxyzine Should NOT Be Used in Second Trimester Pregnancy

Hydroxyzine is contraindicated in early pregnancy according to the FDA label, and this contraindication should be extended to the second trimester for anxiety management given the availability of safer alternatives 1.

Critical Safety Concerns

The FDA drug label explicitly states that hydroxyzine "induced fetal abnormalities in the rat and mouse at doses substantially above the human therapeutic range" and that "clinical data in human beings are inadequate to establish safety in early pregnancy. Until such data are available, hydroxyzine is contraindicated in early pregnancy" 1. While the label specifically mentions "early pregnancy," the lack of adequate human safety data and demonstrated teratogenicity in animal models makes its use inadvisable throughout pregnancy when safer alternatives exist.

Evidence on Pregnancy Safety

The only prospective controlled human study available followed 120 pregnant women exposed to hydroxyzine or cetirizine and found no significant increase in malformations, spontaneous abortions, or adverse pregnancy outcomes 2. However, this 1997 study had only 53 women exposed during organogenesis, which provides insufficient statistical power to detect rare but serious adverse outcomes. This limited evidence does not override the FDA contraindication.

Recommended Alternative Approach

For situational anxiety related to fear of flying in the second trimester, consider the following algorithm:

First-Line: Non-Pharmacological Interventions

• Cognitive-behavioral therapy techniques specifically for flight anxiety
• Relaxation and breathing exercises
• Exposure-based strategies if time permits before travel

Second-Line: Pharmacological Options (if absolutely necessary)

If non-pharmacological approaches are insufficient and the anxiety is severe enough to warrant medication:

1. SSRIs (if ongoing treatment needed): Sertraline or citalopram have better safety profiles in pregnancy for anxiety disorders 3, though these require weeks to achieve therapeutic effect and are not suitable for acute, situational use

2. Avoid benzodiazepines for routine use: While sometimes used in pregnancy, they carry risks and should be reserved for severe cases under specialist guidance

3. Consult maternal-fetal medicine or psychiatry: Given the contraindication and situational nature of this anxiety, specialist input is essential 4

Key Clinical Pitfalls

• Do not assume "second trimester is safer": The FDA contraindication for early pregnancy reflects inadequate human safety data that extends beyond the first trimester
• Situational anxiety may not require medication: A single flight does not typically warrant exposing the fetus to a contraindicated medication
• Patient concerns matter: Pregnant women report significant concerns about medication effects on their babies, which affects adherence and may cause additional anxiety 5

The risk-benefit analysis clearly favors avoiding hydroxyzine in this scenario, as the indication (fear of flying) is situational and non-life-threatening, while the medication carries an FDA contraindication and inadequate human safety data.